Metotrexato Wyeth

Methotrexate, the active ingredient in Metotrexato Wyeth, is an antimetabolite presented as an oral formulation for oral use. It is employed to treat autoimmune disorders and certain malignant diseases in adult patients.\n\nGNH India supplies Metotrexato Wyeth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metotrexato Wyeth is an antimetabolite used across several disease families, primarily autoimmune and oncologic conditions.\n\n- Rheumatoid arthritis: reduces joint inflammation and slows disease progression.\n- Psoriasis: decreases skin cell proliferation and improves plaque appearance.\n- Acute lymphoblastic leukemia: interferes with leukemic cell replication as part of chemotherapy protocols.\n- Osteosarcoma: inhibits tumor growth when combined with other anticancer agents.

Methotrexate may cause a range of adverse reactions, from mild to severe.\n\nCommon Side Effects:\n- Nausea or vomiting: gastrointestinal upset that may occur after dosing.\n- Fatigue: persistent tiredness unrelated to activity level.\n- Mouth sores: ulceration of oral mucosa causing discomfort.\n\nSerious or Rare Side Effects:\n- Severe liver toxicity: marked elevation of liver enzymes or hepatitis.\n- Pulmonary fibrosis: progressive scarring of lung tissue leading to breathing difficulty.\n- Bone marrow suppression: significant drop in blood cell counts increasing infection or bleeding risk.

Careful monitoring and patient counseling are essential when using Metotrexato Wyeth.\n\n- Liver monitoring: perform regular liver function tests to detect hepatotoxicity early.\n- Hematologic monitoring: check complete blood counts frequently to identify bone‑marrow suppression.\n- Pregnancy avoidance: the drug is contraindicated in pregnancy; effective contraception is required for both sexes.\n- Renal function: assess kidney performance before initiation and during therapy.\n- Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methotrexate interacts with several medicines that can alter its efficacy or safety.\n\nMajor Interactions (Avoid):\n- Non‑steroidal anti‑inflammatory drugs (NSAIDs): can increase methotrexate toxicity by reducing renal clearance.\n- Proton pump inhibitors: may raise methotrexate plasma levels, heightening adverse effect risk.\n\nModerate Interactions (Monitor Closely):\n- Trimethoprim‑sulfamethoxazole: may potentiate bone‑marrow suppression.\n- Azathioprine: combined immunosuppression can increase infection susceptibility.\n- Live vaccines: reduced immune response and potential for vaccine‑derived infection.